Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioreactor Controls-III

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...

Scale-Up Processes

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Downstream Processing

Downstream Processing

Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Developing Micro/Nanostructured Fluidic Mixing Technology for Biomedical Applications.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Hierarchical Micro/Nano-Structured Biomaterials for Wound Healing.

Research (Washington, D.C.)·2025

Same author

Genetically Engineered Stromal Cell Exosomes from High-Throughput Herringbone Microfluidics.

ACS nano·2025

Same author

Glycyrrhizic Acid Hydrogel Microparticles Encapsulated with Mesenchymal Stem Cell Exosomes for Wound Healing.

Research (Washington, D.C.)·2024

Same author

Bioinspired Surfaces Derived from Acoustic Waves for On-Demand Droplet Manipulations.

Research (Washington, D.C.)·2024

Same author

Magnetic photonic crystals for biomedical applications.

Smart medicine·2024

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration

Published on: February 2, 2024

Emerging technologies towards extracellular vesicles large-scale production.

Junjie Huang¹, Hanxu Chen¹, Ning Li¹

¹Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.

Bioactive Materials

|June 30, 2025

Summary

This summary is machine-generated.

Researchers are exploring strategies to enhance the production and purification of extracellular vesicles (EVs) for therapeutic applications. Advances in cell culture and isolation methods aim to overcome limitations for clinical translation.

Keywords:

Bioreactor Clinical translation Extracellular vesicles Isolation Large-scale

More Related Videos

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration

Published on: February 2, 2024

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Area of Science:

Biotechnology
Cell Biology
Regenerative Medicine

Background:

Extracellular vesicles (EVs) are crucial for intercellular signaling and hold therapeutic potential.
Current EV production and isolation methods face challenges in yield and scalability.
Standardized, scalable methods are essential for clinical applications of EVs.

Purpose of the Study:

To review strategies for enhancing extracellular vesicle (EV) production and purification.
To discuss bioreactor approaches and alternative EV sources.
To analyze traditional versus advanced isolation techniques and clinical translation challenges.

Main Methods:

Optimizing cell yield and culture scale for EV production.
Exploring alternative EV sources, including non-mammalian organisms and artificial vesicles.
Utilizing bioreactors with controlled culture parameters, media, and stimuli.
Comparing ultracentrifugation with advanced microfluidic isolation methods.

Main Results:

Various strategies can significantly enhance EV production yields.
Bioreactor technology offers precise control over EV biogenesis.
Advanced isolation methods provide improved purity and scalability over traditional techniques.
Overcoming production and purification challenges is key to clinical translation.

Conclusions:

Enhancing EV production and purification is critical for realizing their therapeutic potential.
Integrating advanced technologies promises large-scale EV manufacturing.
Addressing challenges in scaling and standardization will accelerate clinical translation of EVs.